AR117510A1 - COMBINACIONES DE b-LACTAMA Y PROBENECID Y USOS DE LAS MISMAS - Google Patents
COMBINACIONES DE b-LACTAMA Y PROBENECID Y USOS DE LAS MISMASInfo
- Publication number
- AR117510A1 AR117510A1 ARP190103859A ARP190103859A AR117510A1 AR 117510 A1 AR117510 A1 AR 117510A1 AR P190103859 A ARP190103859 A AR P190103859A AR P190103859 A ARP190103859 A AR P190103859A AR 117510 A1 AR117510 A1 AR 117510A1
- Authority
- AR
- Argentina
- Prior art keywords
- probenecid
- lactama
- combinations
- same
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cephalosporin Compounds (AREA)
Abstract
La presente se refiere a comprimidos bicapa que comprenden una segunda capa que comprende un compuesto b-lactama o una sal farmacéuticamente aceptable del mismo; y una primera capa que comprende probenecid o una sal farmacéuticamente aceptable del mismo. La presente también se refiere a métodos para tratar o prevenir una enfermedad usando los comprimidos bicapa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962804973P | 2019-02-13 | 2019-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR117510A1 true AR117510A1 (es) | 2021-08-11 |
Family
ID=69105866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP190103859A AR117510A1 (es) | 2019-02-13 | 2019-12-23 | COMBINACIONES DE b-LACTAMA Y PROBENECID Y USOS DE LAS MISMAS |
Country Status (13)
Country | Link |
---|---|
US (3) | US11478428B2 (es) |
EP (1) | EP3790535A1 (es) |
JP (1) | JP7295964B2 (es) |
KR (1) | KR102577614B1 (es) |
CN (1) | CN112739330A (es) |
AR (1) | AR117510A1 (es) |
AU (1) | AU2019429755B2 (es) |
BR (1) | BR112021015744A2 (es) |
CA (1) | CA3129337A1 (es) |
EA (1) | EA202192193A1 (es) |
MX (1) | MX2021009755A (es) |
TW (1) | TW202045143A (es) |
WO (1) | WO2020164788A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11554112B2 (en) | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
EP3790535A1 (en) | 2019-02-13 | 2021-03-17 | Iterum Therapeutics International Limited | Combinations of beta-lactam compounds and probenecid and uses thereof |
US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
UA59394C2 (uk) * | 1998-03-27 | 2003-09-15 | Каділа Фармацевтікелс (І.Ей) Лтд. | Стійка у фіксованих дозах оральна фармацевтична композиція, що містить антибактеріальний засіб і мікроорганізм одночасно, та спосіб її одержання (варіанти) |
WO2002036126A1 (en) * | 2000-10-30 | 2002-05-10 | Lupin Limited | Rapidly disintegrating sustained release cefuroxime axetil composition |
WO2002041876A1 (en) * | 2000-11-22 | 2002-05-30 | Lupin Limited | Pharmaceutical composition for controlled release of an active ingredient |
DE60117712T2 (de) | 2001-11-19 | 2006-11-16 | Lupin Ltd., Mumbai | Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam-antibiotikums |
CN1853724A (zh) * | 2004-12-01 | 2006-11-01 | 吴晓辉 | 丙磺舒钠、钾与β-内酰胺类抗生素组成复方针剂及其用途 |
CN1813700A (zh) | 2006-03-01 | 2006-08-09 | 吴晓辉 | 丙磺舒钠与青霉素类抗生素组成复方针剂 |
PE20080940A1 (es) * | 2006-06-28 | 2008-07-09 | Pfizer Prod Inc | Profarmacos de penem |
US20080125408A1 (en) | 2006-11-14 | 2008-05-29 | Pfizer Inc | Penem prodrug |
WO2011060256A2 (en) * | 2009-11-13 | 2011-05-19 | Bristol-Myers Squibb Company | Bilayer tablet formulations |
EP2968235B1 (en) * | 2013-03-15 | 2017-09-13 | Janssen Pharmaceutica NV | Combination of canagliflozin and probenecid for the treatment of hyperuricemia |
TR201605632A1 (tr) * | 2016-04-28 | 2017-11-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari |
US11554112B2 (en) | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
EP3790535A1 (en) | 2019-02-13 | 2021-03-17 | Iterum Therapeutics International Limited | Combinations of beta-lactam compounds and probenecid and uses thereof |
-
2019
- 2019-12-23 EP EP19832143.2A patent/EP3790535A1/en active Pending
- 2019-12-23 JP JP2021546900A patent/JP7295964B2/ja active Active
- 2019-12-23 BR BR112021015744A patent/BR112021015744A2/pt unknown
- 2019-12-23 TW TW108147210A patent/TW202045143A/zh unknown
- 2019-12-23 CA CA3129337A patent/CA3129337A1/en active Pending
- 2019-12-23 AU AU2019429755A patent/AU2019429755B2/en active Active
- 2019-12-23 EA EA202192193A patent/EA202192193A1/ru unknown
- 2019-12-23 KR KR1020217029139A patent/KR102577614B1/ko active IP Right Grant
- 2019-12-23 AR ARP190103859A patent/AR117510A1/es unknown
- 2019-12-23 US US16/972,300 patent/US11478428B2/en active Active
- 2019-12-23 WO PCT/EP2019/086975 patent/WO2020164788A1/en active Application Filing
- 2019-12-23 MX MX2021009755A patent/MX2021009755A/es unknown
- 2019-12-23 CN CN201980045618.0A patent/CN112739330A/zh active Pending
- 2019-12-23 US US16/724,527 patent/US20200253878A1/en not_active Abandoned
-
2022
- 2022-09-20 US US17/948,790 patent/US20230138191A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112021015744A2 (pt) | 2021-11-23 |
US11478428B2 (en) | 2022-10-25 |
EP3790535A1 (en) | 2021-03-17 |
KR20210131364A (ko) | 2021-11-02 |
AU2019429755A1 (en) | 2021-08-26 |
US20200253878A1 (en) | 2020-08-13 |
TW202045143A (zh) | 2020-12-16 |
US20230138191A1 (en) | 2023-05-04 |
JP7295964B2 (ja) | 2023-06-21 |
JP2022520788A (ja) | 2022-04-01 |
KR102577614B1 (ko) | 2023-09-12 |
MX2021009755A (es) | 2021-11-17 |
US20210154176A1 (en) | 2021-05-27 |
AU2019429755B2 (en) | 2023-07-20 |
WO2020164788A1 (en) | 2020-08-20 |
CA3129337A1 (en) | 2020-08-20 |
EA202192193A1 (ru) | 2021-11-09 |
CN112739330A (zh) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR117510A1 (es) | COMBINACIONES DE b-LACTAMA Y PROBENECID Y USOS DE LAS MISMAS | |
ECSP20005581A (es) | Compuestos y composiciones para tratar afecciones asociadas con la actividad nlrp | |
CL2018000318A1 (es) | Compuestos derivados de piridinona, inhibidores de bromodominio; composición farmacéutica que los comprende; y su uso en el tratamiento de enfermedades del cáncer. (solicitud divisional 201600925) | |
CL2020001218A1 (es) | Compuestos útiles para inhibir a cdk7. | |
CR20150628A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
NI201900062A (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
NI202000099A (es) | Compuestos de purinona y su uso en el tratamiento del cáncer | |
AR107871A1 (es) | Combinaciones de inhibidores de lsd1 para su uso en el tratamiento de tumores sólidos | |
CL2020002530A1 (es) | Ciano tienotriazolpirazinas y usos de las mismas.(divisional de solicitud 621-2018) | |
AR075369A1 (es) | Comprimidos para terapia de combinacion para el tratamiento de infecciones virales. | |
CO2021009083A2 (es) | Compuestos y su uso para el tratamiento de la deficiencia de α1-antitripsina | |
ECSP20068210A (es) | Moduladores calpaína y usos terapéuticos de los mismos | |
CL2019003258A1 (es) | Composiciones y compuestos terapéuticos y métodos para utilizarlos. | |
DOP2023000251A (es) | Compuestos oligoméricos que inhiben la expresión de hsd17b13 | |
ECSP19026973A (es) | Derivados de naftiridinona y su uso en el tratamiento de la arritmia | |
CO2019007879A2 (es) | Formas cristalinas de tebipenem pivoxil, composiciones que incluyen a las mismas, métodos de fabricación, y métodos de utilización | |
CO2020016480A2 (es) | Sales tópicas de amlodipino para el tratamiento de enfermedades anorrectales | |
UY38006A (es) | Inhibidores de la quinasa mtor, composiciones farmacéuticas que los contienen, y al uso en terapia de tales compuestos y composiciones | |
AR088497A1 (es) | Composiciones farmaceuticas de combinaciones de inhibidores de la dipeptidil peptidasa 4 con atorvastatina | |
AR088845A1 (es) | Composiciones farmaceuticas que contienen 7-(1h-imidazol-4-ilmetil)-5,6,7,8-tetrahidro-quinolina para el tratamiento de las enfermedades y las afecciones de la piel | |
CO2018002046A2 (es) | Nueva composición oral de libreación retardada dual de dexlansoprazol | |
AR115509A1 (es) | COMBINACIONES DE COMPUESTOS DE b-LACTAMA Y PROBENECID Y USOS DE LAS MISMAS | |
CL2014003072A1 (es) | Uso de un compuesto 2-((2r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida (veliparib o abt-888) o de una sal farmaceuticamente aceptable que sirve para el tratamiento de las metástasis en el cerebro con una combinación de una terapia con radiación en la totalidad del cerebro. | |
CR20190323A (es) | Compuestos de ácido ascórbico y quinona para el tratamiento de la enfermedad de chagas | |
AR113817A1 (es) | Compuestos útiles para inhibir a cdk7 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |